Learned lesson from COVID-19: can routine immunizations be the first line of defense against the next pandemic?

Author:

AbdelMassih AntoineORCID,Gaber Hanya,El Shershaby Meryam,Hanafy Maram,Omar Yasmin,Husseiny Reem,AlShehry Nada,Ismail Habiba-Allah,Kamel Aya,Hozaien Rafeef,Khaled Ghadeer,Amer Mohamed,Turki Aya,Fawzy Heba,Puligheddu Stefano,Khaled Dalia,Thabet Nardine Nasry,Abdelaziz Mariam Sherif,Barakat Mustafa,Sharaf Sara,Mohamed Ahmed,Mohsen Dina,El Feky Amr,Adly Hadil,Ibrahim Eman,Mahmoud Rana,Reda Mirna,Riad Felopateer,Vasile Carmen,Shohdi Mahitab Adel,Hesham Nadine,El-Husseiny Nadine,Ragy Rana,Fouda Raghda

Abstract

Abstract Background Single-cell sequencing studies on the lung microenvironment have revealed that the outcome of COVID-19 depends largely on the immune system response rather than the viral load. A robust innate immune response and a regulated adaptive immunity can prevent the worst outcomes such as hospitalization and the need for mechanical ventilation. Main body Intriguingly, several vaccines pertaining to the routine vaccination schedule, not only BCG, can skew the immune response towards the aforementioned beneficial effects. Short conclusion This means that routine immunization not only can help in the current pandemic but can also offer a rapid rescue in the subsequent epidemics or pandemics until a vaccine is developed.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3